![Seong-Jin Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Seong-Jin Kim
Vorstandsvorsitzender bei
MEDPACTO, INC.
Vermögen: 6 Mio $ am 31.08.2026
Profil
Seong-Jin Kim is the founder of MedPacto, Inc. (2013) as Chief Executive Officer, Director & CTO.
Dr. Kim is the founder of Celloram, Inc. (2018) as Director.
Dr. Kim is currently the Head-Cancer Institute at CHA University.
Formerly, Dr. Kim served as Independent Director, Head-Research & Development at THERAGEN ETEX Co., Ltd. Education includes a doctorate from the University of Tsukuba.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MEDPACTO, INC. 6.36% | 30.06.2026 | 2’181’216 ( 6.36% ) | 4 Mio $ | 31.08.2026 |
| 15.03.2025 | 1’059’025 ( 2.85% ) | 2 Mio $ | 31.08.2026 |
Aktive Positionen von Seong-Jin Kim
| Unternehmen | Position | Beginn |
|---|---|---|
| MEDPACTO, INC. | Vorstandsvorsitzender | 19.06.2013 |
CHA University
 CHA University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.07.2011 |
Celloram, Inc.
 Celloram, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies to fight against cancer and metabolic disorders | Gründer | 01.01.2018 |
Ehemalige bekannte Positionen von Seong-Jin Kim
| Unternehmen | Position | Ende |
|---|---|---|
| THERAGEN ETEX CO.,LTD. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Seong-Jin Kim
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
18
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
University of Tsukuba
 University of Tsukuba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
THERAGEN ETEX Co., Ltd.
 THERAGEN ETEX Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
CHA University
CHA University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MedPacto, Inc.
 MedPacto, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops anti-cancer drugs | Health Technology |
Celloram, Inc.
Celloram, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies to fight against cancer and metabolic disorders | Health Technology |
